Rizatriptan
- TRADE NAME: Maxalt (Merck)
- INDICATIONS: Migraine
- CLASS: 5-HT1 agonist, Serotonin receptor agonist, Triptan
- HALF-LIFE: 2–3 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Dihydroergotamine, Ergot-containing drugs, Isocarboxazid, MAO inhibitors, Methysergide, Naratriptan, Phenelzine, Propranolol, Sibutramine, SSRIs, St John's Wort, Sumatriptan, Tranylcypromine, Zolmitriptan
PREGNANCY CATEGORY: C
Please login to see the rest of this drug profile
SKIN.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
GASTROINTESTINAL/HEPATIC.
NEUROMUSCULAR/SKELETAL.
RENAL.
RESPIRATORY.
OTHER.
Page last updated 09/19/2018
Symbol key
Incidence 
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Seriousness
- Hospitalization possible
- Life threatening
- Fatal
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric
